MiMedx Group Inc Common Stock (MDXG)

About MDXG

MiMedx Group, Inc. develops and distributes placental tissue allografts for various sectors of healthcare. The company processes the human placental tissues membrane, and umbilical cord and the placental disc utilizing its patented and proprietary PURION process to produce allografts that retains the tissue's inherent biological properties and regulatory proteins, including cytokines, chemokines, and growth factors.…

Sector

Health Care

Industry

Biotechnology: Pharmaceutical Preparations

Employees

808

Website

mimedx.com/

Fundamentals

1-day range

$4.45$4.74

Market cap

$622.40M

P/E (trailing)

98.12

P/E (forward)

22.55

EPS (trailing)

$0.04

Dividend yield

—

Beta

1.22

Avg. volume

1.34M

Forecasts

5 analyst ratings

MiMedx Group Inc Common Stock Competitors

Chosen by industry and closest market cap.

• MDXG

  MiMedx Group Inc Common Stock

  $4.49

  ▼ 0.44%
  Market cap $622.40MP/E 98.12
  $3.03$7.97
• CRMD

  CorMedix Inc. Common Stock

  $8.31

  ▼ 0.06%
  Market cap $592.31MP/E 3.53
  $6.13$14.96
• BBOT

  BridgeBio Oncology Therapeutics Inc. Common Stock

  $8.74

  ▼ 4.79%
  Market cap $660.88MP/E —
  $7$14.87
• MPLT

  MapLight Therapeutics Inc. Common Stock

  $12.64

  ▲ 0.80%
  Market cap $569.09MP/E —
  $9.1$40.43
• CLYM

  Climb Bio Inc. Common Stock

  $14.56

  ▼ 3.32%
  Market cap $676.28MP/E —
  $1.54$18.33
• OCS

  Oculis Holding AG Ordinary shares

  $12.21

  ▼ 1.77%
  Market cap $689.43MP/E —
  $10.52$34.48
• CTMX

  CytomX Therapeutics Inc. Common Stock

  $3.22

  ▼ 5.99%
  Market cap $690.12MP/E —
  $1.9$8.21

P/E shows — for peers not currently carrying a live signal of their own.

Institutional Ownership

March 31, 2026

Total shares held

110.32M

Total value held

$428.80M

Institutional holders

230